{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:06:33Z","timestamp":1792782393929,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key project of Chongqing Natural Science Foundation","award":["grant number CSTB2023NSCQ-ZDX0007"],"award-info":[{"award-number":["grant number CSTB2023NSCQ-ZDX0007"]}]},{"DOI":"10.13039\/501100005230","name":"the Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["Grant No. CSTB2023NSCQ-MSX0171"],"award-info":[{"award-number":["Grant No. CSTB2023NSCQ-MSX0171"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["grant number 82302060"],"award-info":[{"award-number":["grant number 82302060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02002-x","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:48:18Z","timestamp":1738648098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HMGB1: key mediator in digestive system diseases"],"prefix":"10.1007","volume":"74","author":[{"given":"Hengqian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"1","key":"2002_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00360-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2002_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","journal-title":"J Hepatol"},{"key":"2002_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.684486","author":"L Duan","year":"2021","unstructured":"Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.684486.","journal-title":"Front Pharmacol"},{"issue":"10","key":"2002_CR4","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1007\/s10620-024-08601-8","volume":"69","author":"KM Patel","year":"2024","unstructured":"Patel KM, Zhang J, Marsden J, Bays C, Mauldin PD, Schreiner AD. Missed and delayed diagnoses of chronic liver disease in primary care patients with cirrhosis. Dig Dis Sci. 2024;69(10):3721\u20138. https:\/\/doi.org\/10.1007\/s10620-024-08601-8.","journal-title":"Dig Dis Sci"},{"key":"2002_CR5","doi-asserted-by":"publisher","unstructured":"Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009;462(7269). https:\/\/doi.org\/10.1038\/nature08512.","DOI":"10.1038\/nature08512"},{"key":"2002_CR6","doi-asserted-by":"crossref","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-5. DOI.","DOI":"10.1038\/nature00858"},{"key":"2002_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","volume":"38","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018;38:40\u20138. https:\/\/doi.org\/10.1016\/j.smim.2018.02.011.","journal-title":"Semin Immunol"},{"key":"2002_CR8","doi-asserted-by":"publisher","unstructured":"Taverna S, Tonacci A, Ferraro M, Cammarata G, Cuttitta G, Bucchieri S, et al. High mobility Group Box 1: Biological functions and Relevance in oxidative stress related chronic diseases. Cells. 2022;11(5). https:\/\/doi.org\/10.3390\/cells11050849.","DOI":"10.3390\/cells11050849"},{"issue":"4","key":"2002_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3892\/or.2015.3782","volume":"33","author":"Q-Y Zhang","year":"2015","unstructured":"Zhang Q-Y, Wu L-Q, Zhang T, Han Y-F, Lin X. Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1\/2. Oncol Rep. 2015;33(4):1630\u20138. https:\/\/doi.org\/10.3892\/or.2015.3782.","journal-title":"Oncol Rep"},{"issue":"3","key":"2002_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/j.1460-2075.1992.tb05144.x","volume":"11","author":"ME Bianchi","year":"1992","unstructured":"Bianchi ME, Falciola L, Ferrari S, Lilley DM. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 1992;11(3):1055\u201363.","journal-title":"EMBO J"},{"issue":"51","key":"2002_CR11","doi-asserted-by":"publisher","first-page":"16596","DOI":"10.1021\/bi00051a007","volume":"34","author":"CH Hardman","year":"1995","unstructured":"Hardman CH, Broadhurst RW, Raine AR, Grasser KD, Thomas JO, Laue ED. Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry. 1995;34(51):16596\u2013607.","journal-title":"Biochemistry"},{"key":"2002_CR12","doi-asserted-by":"publisher","unstructured":"Chen R, Kang R, Tang D. The mechanism of HMGB1 secretion and release. Exp Mol Med. 2022;54(2). https:\/\/doi.org\/10.1038\/s12276-022-00736-w.","DOI":"10.1038\/s12276-022-00736-w"},{"issue":"20","key":"2002_CR13","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","volume":"22","author":"T Bonaldi","year":"2003","unstructured":"Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003;22(20):5551\u201360.","journal-title":"EMBO J"},{"issue":"8","key":"2002_CR14","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.1316925111","volume":"111","author":"B Lu","year":"2014","unstructured":"Lu B, Antoine DJ, Kwan K, Lundb\u00e4ck P, W\u00e4h\u00e4maa H, Schierbeck H, et al. JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A. 2014;111(8):3068\u201373. https:\/\/doi.org\/10.1073\/pnas.1316925111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2002_CR15","doi-asserted-by":"publisher","unstructured":"Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Mol Aspects Med. 2014;40. https:\/\/doi.org\/10.1016\/j.mam.2014.05.001.","DOI":"10.1016\/j.mam.2014.05.001"},{"issue":"5","key":"2002_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200911078","volume":"190","author":"D Tang","year":"2010","unstructured":"Tang D, Kang R, Livesey KM, Cheh C-W, Farkas A, Loughran P, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol. 2010;190(5):881\u201392. https:\/\/doi.org\/10.1083\/jcb.200911078.","journal-title":"J Cell Biol"},{"issue":"5","key":"2002_CR17","doi-asserted-by":"publisher","first-page":"L342","DOI":"10.1152\/ajplung.00151.2012","volume":"304","author":"J-M Tadie","year":"2013","unstructured":"Tadie J-M, Bae H-B, Jiang S, Park DW, Bell CP, Yang H, et al. HMGB1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol. 2013;304(5):L342\u20139. https:\/\/doi.org\/10.1152\/ajplung.00151.2012.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2002_CR18","doi-asserted-by":"publisher","unstructured":"Ahrens I, Chen Y-C, Topcic D, Bode M, Haenel D, Hagemeyer CE, et al. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Thromb Haemost. 2015;114(5). https:\/\/doi.org\/10.1160\/TH14-12-1073.","DOI":"10.1160\/TH14-12-1073"},{"issue":"12","key":"2002_CR19","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/ATVBAHA.115.305789","volume":"35","author":"J Cai","year":"2015","unstructured":"Cai J, Yuan H, Wang Q, Yang H, Al-Abed Y, Hua Z, et al. HMGB1-driven inflammation and intimal hyperplasia after arterial injury involves cell-specific actions mediated by TLR4. Arterioscler Thromb Vasc Biol. 2015;35(12):2579\u201393. https:\/\/doi.org\/10.1161\/ATVBAHA.115.305789.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2002_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fimmu.2020.01104","volume":"11","author":"R Li","year":"2020","unstructured":"Li R, Zou X, Huang H, Yu Y, Zhang H, Liu P, et al. HMGB1\/PI3K\/Akt\/mTOR signaling participates in the pathological process of Acute Lung Injury by regulating the maturation and function of dendritic cells. Front Immunol. 2020;11:1104. https:\/\/doi.org\/10.3389\/fimmu.2020.01104.","journal-title":"Front Immunol"},{"issue":"12","key":"2002_CR21","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1161\/ATVBAHA.120.315151","volume":"40","author":"J Lan","year":"2020","unstructured":"Lan J, Luo H, Wu R, Wang J, Zhou B, Zhang Y, et al. Internalization of HMGB1 (high mobility Group Box 1) promotes angiogenesis in endothelial cells. Arterioscler Thromb Vasc Biol. 2020;40(12):2922\u201340. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315151.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2002_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/intimm\/dxx010","volume":"29","author":"K Komai","year":"2017","unstructured":"Komai K, Shichita T, Ito M, Kanamori M, Chikuma S, Yoshimura A. Role of scavenger receptors as damage-associated molecular pattern receptors in toll-like receptor activation. Int Immunol. 2017;29(2):59\u201370. https:\/\/doi.org\/10.1093\/intimm\/dxx010.","journal-title":"Int Immunol"},{"issue":"8","key":"2002_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/1753425916669862","volume":"22","author":"X Chen","year":"2016","unstructured":"Chen X, Li L, Khan MN, Shi L, Wang Z, Zheng F, et al. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production. Innate Immun. 2016;22(8):696\u2013705. https:\/\/doi.org\/10.1177\/1753425916669862.","journal-title":"Innate Immun"},{"key":"2002_CR24","doi-asserted-by":"publisher","first-page":"156537","DOI":"10.1016\/j.cyto.2024.156537","volume":"176","author":"X Chen","year":"2024","unstructured":"Chen X, Bao S, Liu M, Han Z, Tan J, Zhu Q, et al. Inhibition of HMGB1 improves experimental mice colitis by mediating NETs and macrophage polarization. Cytokine. 2024;176:156537. https:\/\/doi.org\/10.1016\/j.cyto.2024.156537.","journal-title":"Cytokine"},{"issue":"Supplement1","key":"2002_CR25","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1093\/ibd\/izac015.089","volume":"28","author":"J Mitchell","year":"2022","unstructured":"Mitchell J, Kim SJ, Howe C, Patel M, Kim G, Heo G, Chronic colitis alters brain activity by inducing HMGB1-mediated pyroptosis in mice, et al. Inflamm Bowel Dis. 2022;28(Supplement1):S56\u2013S. https:\/\/doi.org\/10.1093\/ibd\/izac015.089.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2002_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajpath.2021.09.006","volume":"192","author":"J Mitchell","year":"2022","unstructured":"Mitchell J, Kim SJ, Howe C, Lee S, Her JY, Patel M, et al. Chronic intestinal inflammation suppresses brain activity by inducing neuroinflammation in mice. Am J Pathol. 2022;192(1):72\u201386. https:\/\/doi.org\/10.1016\/j.ajpath.2021.09.006.","journal-title":"Am J Pathol"},{"issue":"11","key":"2002_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.31083\/j.fbl2911387","volume":"29","author":"F Wang","year":"2024","unstructured":"Wang F, Luo L, Wu Z, Wan L, Li F, Wen Z. HMGB1 modulates macrophage metabolism and polarization in ulcerative colitis by inhibiting Cpt1a expression. Front Biosci (Landmark Ed). 2024;29(11):387. https:\/\/doi.org\/10.31083\/j.fbl2911387.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"12","key":"2002_CR28","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1097\/MIB.0000000000000938","volume":"22","author":"F Palone","year":"2016","unstructured":"Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D, et al. Fecal HMGB1 reveals microscopic inflammation in Adult and Pediatric patients with inflammatory bowel disease in clinical and endoscopic remission. Inflamm Bowel Dis. 2016;22(12):2886\u201393.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2002_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4149\/gpb_2024034","volume":"43","author":"X Chen","year":"2024","unstructured":"Chen X, Wu J, Liu M, Han Z, Tan J, Zhu Q, et al. HMGB1 impacts the intestinal epithelial barrier by initiating NETs to regulate macrophage polarization. Gen Physiol Biophys. 2024;43(6):545\u201354. https:\/\/doi.org\/10.4149\/gpb_2024034.","journal-title":"Gen Physiol Biophys"},{"issue":"1","key":"2002_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12964-023-01386-9","volume":"21","author":"K Zhang","year":"2023","unstructured":"Zhang K, Guo J, Yan W, Xu L. Macrophage polarization in inflammatory bowel disease. Cell Commun Signal. 2023;21(1):367. https:\/\/doi.org\/10.1186\/s12964-023-01386-9.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"2002_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ibd\/izac225","volume":"29","author":"W Qian","year":"2023","unstructured":"Qian W, Huang L, Xu Y, Lu W, Wen W, Guo Z, et al. Hypoxic ASCs-derived exosomes attenuate colitis by regulating macrophage polarization via miR-216a-5p\/HMGB1 Axis. Inflamm Bowel Dis. 2023;29(4):602\u201319. https:\/\/doi.org\/10.1093\/ibd\/izac225.","journal-title":"Inflamm Bowel Dis"},{"key":"2002_CR32","doi-asserted-by":"crossref","unstructured":"Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut. 1990;31(9):1037-40. DOI.","DOI":"10.1136\/gut.31.9.1037"},{"issue":"6","key":"2002_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.sleep.2008.12.009","volume":"10","author":"Y Tang","year":"2009","unstructured":"Tang Y, Preuss F, Turek FW, Jakate S, Keshavarzian A. Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med. 2009;10(6):597\u2013603. https:\/\/doi.org\/10.1016\/j.sleep.2008.12.009.","journal-title":"Sleep Med"},{"key":"2002_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.intimp.2019.05.005","volume":"73","author":"X-W Liu","year":"2019","unstructured":"Liu X-W, Wang C-D. Melatonin alleviates circadian rhythm disruption exacerbating DSS-induced colitis by inhibiting the distribution of HMGB1 in intestinal tissues. Int Immunopharmacol. 2019;73:108\u201317. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.005.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2002_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s12026-017-8894-2","volume":"65","author":"X Chen","year":"2017","unstructured":"Chen X, Fang D, Li L, Chen L, Li Q, Gong F, et al. Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells. Immunol Res. 2017;65(3):666\u201380. https:\/\/doi.org\/10.1007\/s12026-017-8894-2.","journal-title":"Immunol Res"},{"key":"2002_CR36","doi-asserted-by":"publisher","first-page":"8653783","DOI":"10.1155\/2020\/8653783","volume":"2020","author":"X-M Zhang","year":"2020","unstructured":"Zhang X-M, Hu X, Ou J-Y, Chen S-S, Nie L-H, Gao L, et al. Glycyrrhizin ameliorates radiation enteritis in mice accompanied by the regulation of the HMGB1\/TLR4 pathway. Evid Based Complement Alternat Med. 2020;2020:8653783. https:\/\/doi.org\/10.1155\/2020\/8653783.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"10","key":"2002_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jgm.2899","volume":"18","author":"X Zheng","year":"2016","unstructured":"Zheng X, Lv Y, Li S, Zhang Q, Zhang X, Hao Z. Adeno-associated virus-mediated colonic secretory expression of HMGB1 A box attenuates experimental colitis in mice. J Gene Med. 2016;18(10):261\u201372. https:\/\/doi.org\/10.1002\/jgm.2899.","journal-title":"J Gene Med"},{"key":"2002_CR38","unstructured":"Mobramaein A. The effects of poly [Adp-Ribose] polymerase 1 (PARP1) on the high mobility Group Box 1 (HMGB1) protein in promoting Colonic inflammation. The University of Arizona.; 2023."},{"key":"2002_CR39","doi-asserted-by":"publisher","unstructured":"Vitali R, Mancuso AB, Palone F, Pioli C, Cesi V, Negroni A, et al. PARP1 activation induces HMGB1 secretion promoting intestinal inflammation in mice and human intestinal organoids. Int J Mol Sci. 2023;24(8). https:\/\/doi.org\/10.3390\/ijms24087096.","DOI":"10.3390\/ijms24087096"},{"key":"2002_CR40","doi-asserted-by":"publisher","unstructured":"Stavely R, Sahakian L, Filippone RT, Stojanovska V, Bornstein JC, Sakkal S, et al. Oxidative stress-Induced HMGB1 translocation in myenteric neurons contributes to Neuropathy in Colitis. Biomolecules. 2022;12(12). https:\/\/doi.org\/10.3390\/biom12121831.","DOI":"10.3390\/biom12121831"},{"issue":"3","key":"2002_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/ibd\/izaa161","volume":"27","author":"L Sahakian","year":"2021","unstructured":"Sahakian L, Filippone RT, Stavely R, Robinson AM, Yan XS, Abalo R, et al. Inhibition of APE1\/Ref-1 Redox signaling alleviates intestinal dysfunction and damage to myenteric neurons in a mouse model of spontaneous chronic colitis. Inflamm Bowel Dis. 2021;27(3):388\u2013406. https:\/\/doi.org\/10.1093\/ibd\/izaa161.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2002_CR42","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1038\/s41598-024-57070-6","volume":"14","author":"R Stavely","year":"2024","unstructured":"Stavely R, Robinson AM, Fraser S, Filippone RT, Stojanovska V, Eri R, et al. Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms. Sci Rep. 2024;14(1):6649. https:\/\/doi.org\/10.1038\/s41598-024-57070-6.","journal-title":"Sci Rep"},{"key":"2002_CR43","volume-title":"Mechanisms of mesenchymal stem cell therapy for enteric Neuropathy Associated","author":"R Stavely","year":"2018","unstructured":"Stavely R. Mechanisms of mesenchymal stem cell therapy for enteric Neuropathy Associated. with Colitis: Victoria University; 2018."},{"issue":"5","key":"2002_CR44","doi-asserted-by":"publisher","first-page":"e0184922","DOI":"10.1128\/mbio.01849-22","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Xu W, Ren Y, Cheung H-C, Huang P, Kaur G, et al. Plakoglobin and high-mobility group box 1 mediate intestinal epithelial cell apoptosis Induced by Clostridioides difficile TcdB. mBio. 2022;13(5):e0184922. https:\/\/doi.org\/10.1128\/mbio.01849-22.","journal-title":"mBio"},{"key":"2002_CR45","doi-asserted-by":"publisher","unstructured":"Guo H, Zhang L, Wang Y, He X. Mechanisms of HuR in regulation of epithelial cell apoptosis in rat ulcerative colitis. Cell Signal. 2021;82. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109957.","DOI":"10.1016\/j.cellsig.2021.109957"},{"issue":"suppl1","key":"2002_CR46","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1097\/01.MIB.0000512750.37987.d3","volume":"23","author":"J Messer","year":"2017","unstructured":"Messer J, Cham C, Zhu X, Patno N, Tao Y, Chang E. PD-235 targeting HMGB1-dependent survival and energy production pathways to improve mucosal healing during IBD. Inflamm Bowel Dis. 2017;23(suppl1):S77\u2013S. https:\/\/doi.org\/10.1097\/01.MIB.0000512750.37987.d3.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"2002_CR47","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1080\/15548627.2019.1596485","volume":"15","author":"Y-G Zhang","year":"2019","unstructured":"Zhang Y-G, Zhu X, Lu R, Messer JS, Xia Y, Chang EB, et al. Intestinal epithelial HMGB1 inhibits bacterial infection via STAT3 regulation of autophagy. Autophagy. 2019;15(11):1935\u201353. https:\/\/doi.org\/10.1080\/15548627.2019.1596485.","journal-title":"Autophagy"},{"key":"2002_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae017","author":"K Foelsch","year":"2024","unstructured":"Foelsch K, Pelczar P, Zierz E, Kondratowicz S, Qi M, M\u00fcller C, et al. Intestinal epithelia and myeloid immune cells shape colitis severity and colorectal carcinogenesis via high-mobility group box protein 1. J Crohns Colitis. 2024. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae017.","journal-title":"J Crohns Colitis"},{"issue":"Supplement1","key":"2002_CR49","doi-asserted-by":"publisher","first-page":"i098","DOI":"10.1093\/ecco-jcc\/jjab232.088","volume":"16","author":"E Zierz","year":"2022","unstructured":"Zierz E, Foelsch K, Pelczar P, Qi M, Alawi M, Clauditz T, et al. DOP49 context-dependent roles of high-mobility group box 1 (HMGB1) during intestinal inflammation and carcinogenesis. J Crohn\u2019s Colitis. 2022;16(Supplement1):i098\u2013i. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab232.088.","journal-title":"J Crohn\u2019s Colitis"},{"key":"2002_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.dci.2018.09.006","volume":"92","author":"X Chen","year":"2019","unstructured":"Chen X, Fu Y, Wang L, Qian W, Zheng F, Hou X. Bifidobacterium longum and VSL#3\u00ae amelioration of TNBS-induced colitis associated with reduced HMGB1 and epithelial barrier impairment. Dev Comp Immunol. 2019;92:77\u201386. https:\/\/doi.org\/10.1016\/j.dci.2018.09.006.","journal-title":"Dev Comp Immunol"},{"key":"2002_CR51","doi-asserted-by":"publisher","unstructured":"Stronati L, Palone F, Negroni A, Colantoni E, Mancuso AB, Cucchiara S, et al. Dipotassium glycyrrhizate improves intestinal mucosal healing by modulating extracellular matrix remodeling genes and restoring epithelial barrier functions. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.00939.","DOI":"10.3389\/fimmu.2019.00939"},{"key":"2002_CR52","doi-asserted-by":"publisher","unstructured":"Konno T, Kohno T, Miyakawa M, Tanaka H, Kojima T. Pyk2 inhibitor prevents epithelial hyperpermeability induced by HMGB1 and inflammatory cytokines in Caco-2 cells. Tissue Barriers. 2021;9(2). https:\/\/doi.org\/10.1080\/21688370.2021.1890526.","DOI":"10.1080\/21688370.2021.1890526"},{"issue":"3","key":"2002_CR53","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/liv.15811","volume":"44","author":"C Wang","year":"2024","unstructured":"Wang C, Leng M, Ding C, Zhu X, Zhang Y, Sun C, et al. Ferritinophagy-mediated ferroptosis facilitates methotrexate-induced hepatotoxicity by high-mobility group box 1 (HMGB1). Liver Int. 2024;44(3):691\u2013705. https:\/\/doi.org\/10.1111\/liv.15811.","journal-title":"Liver Int"},{"key":"2002_CR54","doi-asserted-by":"publisher","first-page":"106413","DOI":"10.1016\/j.ejps.2023.106413","volume":"184","author":"Y Xue","year":"2023","unstructured":"Xue Y, Zhang D, Wei Y, Guo C, Song B, Cui Y, et al. Polymeric nano-micelle of carbon monoxide donor SMA\/CORM2 ameliorates acetaminophen-induced liver injury via suppressing HMGB1\/TLR4 signaling pathway. Eur J Pharm Sci. 2023;184:106413. https:\/\/doi.org\/10.1016\/j.ejps.2023.106413.","journal-title":"Eur J Pharm Sci"},{"key":"2002_CR55","doi-asserted-by":"publisher","first-page":"1116841","DOI":"10.1155\/2023\/1116841","volume":"2023","author":"H Du","year":"2023","unstructured":"Du H, Tong S, Kuang G, Gong X, Jiang N, Yang X, et al. Sesamin protects against APAP-Induced Acute Liver Injury by inhibiting oxidative stress and inflammatory response via deactivation of HMGB1\/TLR4\/NF\u03baB Signal in mice. J Immunol Res. 2023;2023:1116841. https:\/\/doi.org\/10.1155\/2023\/1116841.","journal-title":"J Immunol Res"},{"issue":"12","key":"2002_CR56","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/hep4.1777","volume":"5","author":"A Volmari","year":"2021","unstructured":"Volmari A, Foelsch K, Zierz E, Yan K, Qi M, Bartels K, et al. Leukocyte-derived high-mobility Group Box 1 governs hepatic Immune responses to Listeria monocytogenes. Hepatol Commun. 2021;5(12):2104\u201320. https:\/\/doi.org\/10.1002\/hep4.1777.","journal-title":"Hepatol Commun"},{"key":"2002_CR57","doi-asserted-by":"publisher","first-page":"174497","DOI":"10.1016\/j.ejphar.2021.174497","volume":"910","author":"J-M Lu","year":"2021","unstructured":"Lu J-M, Jin G-N, Lu Y-N, Zhao X-D, Lan H-W, Mu S-R, et al. Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1\/TLR4\/NF-\u03baB signaling pathway. Eur J Pharmacol. 2021;910:174497. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174497.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2002_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41420-021-00729-0","volume":"7","author":"G Wang","year":"2021","unstructured":"Wang G, Jin S, Huang W, Li Y, Wang J, Ling X, et al. LPS-induced macrophage HMGB1-loaded extracellular vesicles trigger hepatocyte pyroptosis by activating the NLRP3 inflammasome. Cell Death Discov. 2021;7(1):337. https:\/\/doi.org\/10.1038\/s41420-021-00729-0.","journal-title":"Cell Death Discov"},{"issue":"5","key":"2002_CR59","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s12072-020-10068-4","volume":"14","author":"X Zhang","year":"2020","unstructured":"Zhang X, Lin Y, Lin S, Li C, Gao J, Feng Z, et al. Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction. Hepatol Int. 2020;14(5):828\u201341. https:\/\/doi.org\/10.1007\/s12072-020-10068-4.","journal-title":"Hepatol Int"},{"key":"2002_CR60","doi-asserted-by":"publisher","first-page":"122139","DOI":"10.1016\/j.carbpol.2024.122139","volume":"337","author":"X Jing","year":"2024","unstructured":"Jing X, Zhou G, Zhu A, Jin C, Li M, Ding K. RG-I pectin-like polysaccharide from Rosa chinensis inhibits inflammation and fibrosis associated to HMGB1\/TLR4\/NF-\u03baB signaling pathway to improve non-alcoholic steatohepatitis. Carbohydr Polym. 2024;337:122139. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122139.","journal-title":"Carbohydr Polym"},{"issue":"6","key":"2002_CR61","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/gutjnl-2015-310752","volume":"66","author":"E Arriazu","year":"2017","unstructured":"Arriazu E, Ge X, Leung T-M, Magdaleno F, Lopategi A, Lu Y, et al. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury. Gut. 2017;66(6):1123\u201337. https:\/\/doi.org\/10.1136\/gutjnl-2015-310752.","journal-title":"Gut"},{"issue":"10","key":"2002_CR62","doi-asserted-by":"publisher","first-page":"130202","DOI":"10.1016\/j.bbagen.2022.130202","volume":"1866","author":"M Wei","year":"2022","unstructured":"Wei M, Zhang Y, Zhang H, Huang Z, Miao H, Zhang T, et al. HMGB1 induced endothelial to mesenchymal transition in liver fibrosis: the key regulation of early growth response factor 1. Biochim Biophys Acta Gen Subj. 2022;1866(10):130202. https:\/\/doi.org\/10.1016\/j.bbagen.2022.130202.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"12","key":"2002_CR63","doi-asserted-by":"publisher","first-page":"eabg9055","DOI":"10.1126\/sciadv.abg9055","volume":"8","author":"J Personnaz","year":"2022","unstructured":"Personnaz J, Piccolo E, Dortignac A, Iacovoni JS, Mariette J, Rocher V, et al. Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor. Sci Adv. 2022;8(12):eabg9055. https:\/\/doi.org\/10.1126\/sciadv.abg9055.","journal-title":"Sci Adv"},{"key":"2002_CR64","doi-asserted-by":"publisher","first-page":"155769","DOI":"10.1016\/j.metabol.2023.155769","volume":"152","author":"J Du","year":"2024","unstructured":"Du J, Ji X, Xu B, Du Q, Li Y, Zhou B, et al. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease. Metabolism. 2024;152:155769. https:\/\/doi.org\/10.1016\/j.metabol.2023.155769.","journal-title":"Metabolism"},{"key":"2002_CR65","doi-asserted-by":"publisher","first-page":"118619","DOI":"10.1016\/j.lfs.2020.118619","volume":"264","author":"M Tang","year":"2021","unstructured":"Tang M, Jia H, Chen S, Yang B, Patpur BK, Song W, et al. Significance of MR\/OPN\/HMGB1 axis in NAFLD-associated hepatic fibrogenesis. Life Sci. 2021;264:118619. https:\/\/doi.org\/10.1016\/j.lfs.2020.118619.","journal-title":"Life Sci"},{"issue":"12","key":"2002_CR66","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/hepr.13825","volume":"52","author":"Y Ishii","year":"2022","unstructured":"Ishii Y, Tsuchiya A, Natsui K, Koseki Y, Takeda N, Tomiyoshi K, et al. Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non-alcoholic steatohepatitis mouse model. Hepatol Res. 2022;52(12):985\u201397. https:\/\/doi.org\/10.1111\/hepr.13825.","journal-title":"Hepatol Res"},{"issue":"3","key":"2002_CR67","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbrc.2018.12.180","volume":"509","author":"Y Chen","year":"2019","unstructured":"Chen Y, Sun H, Bai Y, Zhi F. Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice. Biochem Biophys Res Commun. 2019;509(3):767\u201372. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.180.","journal-title":"Biochem Biophys Res Commun"},{"key":"2002_CR68","doi-asserted-by":"publisher","unstructured":"Gaskell H, Ge X, Desert R, Das S, Han H, Lantvit D, et al. Ablation of Hmgb1 in intestinal epithelial cells causes intestinal lipid accumulation and reduces NASH in mice. Hepatol Commun. 2020;4(1). https:\/\/doi.org\/10.1002\/hep4.1448.","DOI":"10.1002\/hep4.1448"},{"issue":"1","key":"2002_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/13813455.2021.1975758","volume":"130","author":"MM Allam","year":"2024","unstructured":"Allam MM, Ibrahim RM, El Gazzar WB, Said MA. Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1\/TLR4\/NF-\u03baB signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease. Arch Physiol Biochem. 2024;130(1):87\u201395. https:\/\/doi.org\/10.1080\/13813455.2021.1975758.","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"2002_CR70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10020-019-0099-9","volume":"25","author":"C Zhang","year":"2019","unstructured":"Zhang C, Chen F, Feng L, Shan Q, Zheng G-H, Wang Y-J, et al. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. Mol Med. 2019;25(1):29. https:\/\/doi.org\/10.1186\/s10020-019-0099-9.","journal-title":"Mol Med"},{"key":"2002_CR71","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.jnutbio.2022.109020","volume":"106","author":"H Miao","year":"2022","unstructured":"Miao H, Ouyang H, Guo Q, Wei M, Lu B, Kai G, et al. Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism. J Nutr Biochem. 2022;106:109020. https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109020.","journal-title":"J Nutr Biochem"},{"key":"2002_CR72","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","volume":"343","author":"J-E Zhou","year":"2022","unstructured":"Zhou J-E, Sun L, Liu L, Jia Y, Han Y, Shao J, et al. Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J Control Release. 2022;343:175\u201386. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.038.","journal-title":"J Control Release"},{"key":"2002_CR73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","volume":"44","author":"R Afrin","year":"2017","unstructured":"Afrin R, Arumugam S, Rahman A, Wahed MII, Karuppagounder V, Harima M, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-\u03baB translocation. Int Immunopharmacol. 2017;44:174\u201382. https:\/\/doi.org\/10.1016\/j.intimp.2017.01.016.","journal-title":"Int Immunopharmacol"},{"key":"2002_CR74","doi-asserted-by":"publisher","first-page":"176178","DOI":"10.1016\/j.ejphar.2023.176178","volume":"960","author":"HH Zeng","year":"2023","unstructured":"Zeng HH, Ma M, Wang YL, Chen MH, Huang DB. Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway. Eur J Pharmacol. 2023;960:176178. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176178.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2002_CR75","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/tox.23458","volume":"37","author":"C Wan","year":"2022","unstructured":"Wan C, Gu T, Ling J, Qin Y, Luo J, Sun L, et al. Perfluorooctane sulfonate aggravates CCl4-induced hepatic fibrosis via HMGB1\/TLR4\/Smad signaling. Environ Toxicol. 2022;37(5):983\u201394. https:\/\/doi.org\/10.1002\/tox.23458.","journal-title":"Environ Toxicol"},{"key":"2002_CR76","doi-asserted-by":"publisher","first-page":"113197","DOI":"10.1016\/j.biopha.2022.113197","volume":"152","author":"W-I Ho","year":"2022","unstructured":"Ho W-I, Hu Y, Cheng C-W, Wei R, Yang J, Li N, et al. Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson\u2019s disease. Biomed Pharmacother. 2022;152:113197. https:\/\/doi.org\/10.1016\/j.biopha.2022.113197.","journal-title":"Biomed Pharmacother"},{"key":"2002_CR77","doi-asserted-by":"publisher","first-page":"155502","DOI":"10.1016\/j.phymed.2024.155502","volume":"128","author":"Y Yao","year":"2024","unstructured":"Yao Y, Zuo X, Shao F, Yu K, Liang Q. Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3\/HMGB1\/TLR4 signaling pathway. Phytomedicine. 2024;128:155502. https:\/\/doi.org\/10.1016\/j.phymed.2024.155502.","journal-title":"Phytomedicine"},{"key":"2002_CR78","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fphar.2020.00582","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Huang K, Zhang RJ, Mei D, Zhang B. Isochlorogenic acid a attenuates the progression of liver fibrosis through regulating HMGB1\/TLR4\/NF-\u03baB signaling pathway. Front Pharmacol. 2020;11:582. https:\/\/doi.org\/10.3389\/fphar.2020.00582.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2002_CR79","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jhep.2023.11.005","volume":"80","author":"X Ge","year":"2024","unstructured":"Ge X, Desert R, Magdaleno F, Han H, Song Z, Das S, et al. Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice. J Hepatol. 2024;80(3):482\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2023.11.005.","journal-title":"J Hepatol"},{"key":"2002_CR80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1515\/med-2017-0043","volume":"12","author":"G Wang","year":"2017","unstructured":"Wang G, Liu Y, Dui D, Bai L, Liu Y, Tian F, et al. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells. Open Med (Wars). 2017;12:293\u20138. https:\/\/doi.org\/10.1515\/med-2017-0043.","journal-title":"Open Med (Wars)"},{"key":"2002_CR81","doi-asserted-by":"publisher","unstructured":"Li G, Wu X, Yang L, He Y, Liu Y, Jin X, et al. TLR4-mediated NF-\u03baB signaling pathway mediates HMGB1-induced pancreatic injury in mice with severe acute pancreatitis. Int J Mol Med. 2016;37(1). https:\/\/doi.org\/10.3892\/ijmm.2015.2410.","DOI":"10.3892\/ijmm.2015.2410"},{"issue":"4","key":"2002_CR82","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11481-017-9757-2","volume":"12","author":"Y Irie","year":"2017","unstructured":"Irie Y, Tsubota M, Ishikura H, Sekiguchi F, Terada Y, Tsujiuchi T, et al. Macrophage-derived HMGB1 as a pain mediator in the early stage of acute pancreatitis in mice: targeting RAGE and CXCL12\/CXCR4 Axis. J Neuroimmune Pharmacol. 2017;12(4):693\u2013707. https:\/\/doi.org\/10.1007\/s11481-017-9757-2.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2002_CR83","doi-asserted-by":"publisher","first-page":"119231","DOI":"10.1016\/j.lfs.2021.119231","volume":"286","author":"X Wu","year":"2021","unstructured":"Wu X, Yang Z, Wang H, Zhao Y, Gao X, Zang B. High-mobility group box protein-1 induces acute pancreatitis through activation of neutrophil extracellular trap and subsequent production of IL-1\u03b2. Life Sci. 2021;286:119231. https:\/\/doi.org\/10.1016\/j.lfs.2021.119231.","journal-title":"Life Sci"},{"issue":"3","key":"2002_CR84","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pan.2016.03.004","volume":"16","author":"H Zhu","year":"2016","unstructured":"Zhu H, Huang L, Zhu S, Li X, Li Z, Yu C, et al. Regulation of autophagy by systemic admission of microRNA-141 to target HMGB1 in l-arginine-induced acute pancreatitis in vivo. Pancreatology. 2016;16(3):337\u201346. https:\/\/doi.org\/10.1016\/j.pan.2016.03.004.","journal-title":"Pancreatology"},{"issue":"2","key":"2002_CR85","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3892\/etm.2021.11063","volume":"23","author":"Y Gao","year":"2022","unstructured":"Gao Y, Wang L, Niu Z, Feng H, Liu J, Sun J, et al. Mir-340-5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1. Exp Ther Med. 2022;23(2):140. https:\/\/doi.org\/10.3892\/etm.2021.11063.","journal-title":"Exp Ther Med"},{"issue":"8","key":"2002_CR86","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00535-024-02112-z","volume":"59","author":"D Hokkoku","year":"2024","unstructured":"Hokkoku D, Sasaki K, Kobayashi S, Shimbo T, Kitayama T, Yamazaki S, et al. High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice. J Gastroenterol. 2024;59(8):744\u201357. https:\/\/doi.org\/10.1007\/s00535-024-02112-z.","journal-title":"J Gastroenterol"},{"issue":"1","key":"2002_CR87","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1038\/s41598-017-07094-y","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X, Zhao H-X, Bai C, Zhou X-Y. Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis. Sci Rep. 2017;7(1):6799. https:\/\/doi.org\/10.1038\/s41598-017-07094-y.","journal-title":"Sci Rep"},{"issue":"8","key":"2002_CR88","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00011-019-01251-x","volume":"68","author":"L Huang","year":"2019","unstructured":"Huang L, Zhang D, Han W, Guo C. High-mobility group box-1 inhibition stabilizes intestinal permeability through tight junctions in experimental acute necrotizing pancreatitis. Inflamm Res. 2019;68(8):677\u201389. https:\/\/doi.org\/10.1007\/s00011-019-01251-x.","journal-title":"Inflamm Res"},{"issue":"12","key":"2002_CR89","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2174\/1389201021666201218130440","volume":"22","author":"C Qiu","year":"2021","unstructured":"Qiu C, Liu K, Li X, Chen W, Zhang S, Huang Y. Restoration of intestinal mucosa in Euphorbia kansui-treated severe Acute pancreatitis rats based on HMGB1\/MFG-E8 expression. Curr Pharm Biotechnol. 2021;22(12):1672\u201382. https:\/\/doi.org\/10.2174\/1389201021666201218130440.","journal-title":"Curr Pharm Biotechnol"},{"issue":"9","key":"2002_CR90","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3748\/wjg.v27.i9.815","volume":"27","author":"S-Q Huang","year":"2021","unstructured":"Huang S-Q, Wen Y, Sun H-Y, Deng J, Zhang Y-L, Huang Q-L, et al. Abdominal paracentesis drainage attenuates intestinal inflammation in rats with severe acute pancreatitis by inhibiting the HMGB1-mediated TLR4 signaling pathway. World J Gastroenterol. 2021;27(9):815\u201334. https:\/\/doi.org\/10.3748\/wjg.v27.i9.815.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2002_CR91","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s11655-023-3562-y","volume":"30","author":"J Li","year":"2024","unstructured":"Li J, Chen Y-F, Gao L, Li Y-J, Feng D-X. Honokiol prevents intestinal barrier dysfunction in mice with severe Acute Pancreatitis and inhibits JAK\/STAT1 pathway and acetylation of HMGB1. Chin J Integr Med. 2024;30(6):534\u201342. https:\/\/doi.org\/10.1007\/s11655-023-3562-y.","journal-title":"Chin J Integr Med"},{"key":"2002_CR92","doi-asserted-by":"publisher","first-page":"174279","DOI":"10.1016\/j.ejphar.2021.174279","volume":"906","author":"ME Abdelmageed","year":"2021","unstructured":"Abdelmageed ME, Nader MA, Zaghloul MS. Targeting HMGB1\/TLR4\/NF-\u03baB signaling pathway by protocatechuic acid protects against l-arginine induced acute pancreatitis and multiple organs injury in rats. Eur J Pharmacol. 2021;906:174279. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174279.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2002_CR93","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.26355\/eurrev_202002_20390","volume":"24","author":"H Zhou","year":"2020","unstructured":"Zhou H, Zhu ZH, Liu Y, Liu YY. Effects of midazolam combined with sufentanil on injury and expression of HMGB1 and NF-\u03baB in rats with pancreatitis. Eur Rev Med Pharmacol Sci. 2020;24(4):2102\u20139. https:\/\/doi.org\/10.26355\/eurrev_202002_20390.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2002_CR94","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.3892\/mmr.2018.9595","volume":"18","author":"S Zhao","year":"2018","unstructured":"Zhao S, Yang J, Liu T, Zeng J, Mi L, Xiang K. Dexamethasone inhibits NF\u2013\u043aBp65 and HMGB1 expression in the pancreas of rats with severe acute pancreatitis. Mol Med Rep. 2018;18(6):5345\u201352. https:\/\/doi.org\/10.3892\/mmr.2018.9595.","journal-title":"Mol Med Rep"},{"key":"2002_CR95","unstructured":"Pan L-F, Yu L, Wang L-M, He J-T, Sun J-L, Wang X-B et al. Augmenter of liver regeneration (ALR) regulates acute pancreatitis via inhibiting HMGB1\/TLR4\/NF-\u03baB signaling pathway. Am J Transl Res. 2018;10(2):402\u2013\u200910. DOI."},{"issue":"1","key":"2002_CR96","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12974-021-02274-0","volume":"18","author":"S-W Tan","year":"2021","unstructured":"Tan S-W, Zhao Y, Li P, Ning Y-L, Huang Z-Z, Yang N, et al. HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury. J Neuroinflammation. 2021;18(1):241. https:\/\/doi.org\/10.1186\/s12974-021-02274-0.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2002_CR97","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.bbrc.2018.02.102","volume":"497","author":"T Gao","year":"2018","unstructured":"Gao T, Chen Z, Chen H, Yuan H, Wang Y, Peng X, et al. Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia\/macrophage polarization. Biochem Biophys Res Commun. 2018;497(1):430\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.102.","journal-title":"Biochem Biophys Res Commun"},{"key":"2002_CR98","doi-asserted-by":"publisher","unstructured":"Adewuyi EO, O\u2019Brien EK, Porter T, Laws SM. Relationship of cognition and alzheimer\u2019s disease with gastrointestinal tract disorders: a large-scale genetic overlap and mendelian randomisation analysis. Int J Mol Sci. 2022;23(24). https:\/\/doi.org\/10.3390\/ijms232416199.","DOI":"10.3390\/ijms232416199"},{"key":"2002_CR99","doi-asserted-by":"publisher","first-page":"109575","DOI":"10.1016\/j.neuropharm.2023.109575","volume":"236","author":"RM Essam","year":"2023","unstructured":"Essam RM, Saadawy MA, Gamal M, Abdelsalam RM, El-Sahar AE. Lactoferrin averts neurological and behavioral impairments of thioacetamide-induced hepatic encephalopathy in rats via modulating HGMB1\/TLR-4\/MyD88\/Nrf2 pathway. Neuropharmacology. 2023;236:109575. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109575.","journal-title":"Neuropharmacology"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02002-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:55:50Z","timestamp":1767200150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02002-x","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"34"}}